跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,162 条关于
“nirmatrelvir/ritonavir (Paxlovid)”
全部
1,162
临床试验
1,006
药物
82
机构
0
资讯
74
9个月前
COVID-19 Antivirals Nirmatrelvir/Ritonavir and Molnupiravir Show Promise in Reducing Cardiovascular Risks
2年前
Paxlovid Reduces Risk of Long COVID and Post-Acute Hospitalization or Death in High-Risk Patients
去年
Extended Paxlovid Treatment Reduces Viral Rebound in Immunocompromised COVID-19 Patients
去年
Azvudine Shows Comparable Effectiveness to Nirmatrelvir/Ritonavir for COVID-19 Patients with Chronic Liver Disease
2年前
Paxlovid's Efficacy Questioned in Lower-Risk COVID-19 Patients
上个月
19F NMR Reveals Hidden Bound-State Dynamics of SARS-CoV-2 3CLpro-Inhibitor Complexes, Guiding Next-Generation Antiviral Design
去年
COVID-19 Therapeutics: Paxlovid's Utility and Novel Approaches in Development
去年
Low Incidence of SARS-CoV-2 Resistance to Paxlovid Observed in Clinical Trials
去年
FDA Revokes Emergency Use Authorizations for Four COVID-19 Monoclonal Antibody Products
去年
Paxlovid Reduces Hospitalization and Death Risks in COVID-19 Patients with Kidney Disease
第 1 页，共 8 页
上一页
下一页
